SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-286850
Filing Date
2020-11-05
Accepted
2020-11-05 16:23:37
Documents
3
Period of Report
2020-11-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d97355d8k.htm 8-K 20976
2 EX-3.1 d97355dex31.htm EX-3.1 32188
3 EX-3.2 d97355dex32.htm EX-3.2 220585
  Complete submission text file 0001193125-20-286850.txt   274908
Mailing Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110
Business Address 125 SUMMER STREET 16TH FLOOR BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

IRS No.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39661 | Film No.: 201290825
SIC: 2834 Pharmaceutical Preparations